Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Methocarbamol (Only 1500 Mg), Atc M03ba03 for the Period February 1St, 2023 - January 31St, 2025. The project location is Germany and the tender is closing on 05 Dec 2024. The tender notice number is 708527-2022, while the TOT Ref Number is 76419884. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Methocarbamol (Only 1500 Mg), Atc M03ba03 for the Period February 1St, 2023 - January 31St, 2025
Deadline : 05 Dec 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 76419884
Document Ref. No. : 708527-2022
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 1.00
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
§ 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the relevant statutory provisions on the award of public contracts, findet a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned Active substance methocarbamol (exclusively 1500 mg), ATC M03BA03, DAK-Gesundheit intends to conclude drug discount contracts with as many interested pharmaceutical companies as possible before new drug discount contracts come into force. A discount agreement in the context of the admission model for the above Active substance comes into force for the first time on February 1st, 2023nd ends on 01/31/2025. Irrespective of this, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 1003818 - Methocarbamol (ausschliesslich 1500 mg), ATC M03BA03
Contract Type : Supplies
Estimated Value : 1.00 - EUR
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2022-12-15
Publish Date : 2022-12-20
Submission Date : 2024-12-05
Documents
Want To Bid in This Tender?
Get Local Agent Support in Germany and 60 More Countries.
View Tenders By
Sign in with Google